Richard Narido
Director of Finance/CFO bij NRX PHARMACEUTICALS, INC.
Profiel
Richard Narido is currently the Chief Financial & Accounting Officer at NRX Pharmaceuticals, Inc. He previously worked as the Head-Finance, Treasury & Executive Director at Assembly Biosciences, Inc. from 2018 to 2021.
Prior to that, he was the Vice President-Finance at Lucira Health, Inc. from 2021 to 2022.
From 2014 to 2018, he served as the Head-Finance & Global Commercial Operations at Bio-Rad Laboratories, Inc. He also worked as a Business Unit Controller at McKesson Corp.
from 2006 to 2010.
Mr. Narido obtained his undergraduate degree from the University of San Francisco and his graduate degree from Pepperdine Graziadio Business School.
Actieve functies van Richard Narido
| Bedrijven | Functie | Begin |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Director of Finance/CFO | 13-09-2023 |
Eerdere bekende functies van Richard Narido
| Bedrijven | Functie | Einde |
|---|---|---|
| LUCIRA HEALTH, INC. | Director of Finance/CFO | 01-04-2023 |
| ASSEMBLY BIOSCIENCES, INC. | Director of Finance/CFO | 01-03-2021 |
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 01-06-2018 |
| MCKESSON CORPORATION | Corporate Officer/Principal | 01-11-2010 |
Opleiding van Richard Narido
| University of San Francisco | Undergraduate Degree |
| Pepperdine Graziadio Business School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| MCKESSON CORPORATION | Distribution Services |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| NRX PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Lucira Health, Inc.
 Lucira Health, Inc. Medical SpecialtiesHealth Technology Lucira Health, Inc. is a medical technology company, which engages in the business of developing and commercializing transformative and innovative infectious disease test kits. It operates through the following customer segments: the United States Healthcare (US Healthcare), United States Business to Business and Government (US Business to Business and Government), Direct to Consumer (DTC), and International. The US Healthcare segment provides solutions of choice for certain telehealth platforms and providers who are able to confirm diagnosis immediately and over a telehealth platform to drive treatment. The US Business to Business and Government segment is involved in selling OTC test kits to both employers and government organizations. The DTC segment includes selling directly to the individual consumer through online platforms. The International segment focuses on selling tests into Canada, Taiwan, Singapore, and Israel. The company was founded by Debkishore Mitra, John Robert Waldeisen, and Benjamin Ross on February 20, 2013 and is headquartered in Emeryville, CA. | Health Technology |
